Avenue Therapeutics Financials
| ATXIDelisted Stock | USD 0.36 0.02 5.26% |
Avenue |
Understanding current and past Avenue Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Avenue Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Avenue Therapeutics' assets may result in an increase in income on the income statement.
Avenue Therapeutics Stock Summary
Avenue Therapeutics competes with Hoth Therapeutics, Revelation Biosciences, Virax Biolabs, Palisade Bio, and Quoin Pharmaceuticals. Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acuteintensive care hospital setting. The company was incorporated in 2015 and is based in New York, New York. Avenue Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US05360L3042 |
| CUSIP | 05360L205 05360L304 05360L403 |
| Location | New York; U.S.A |
| Business Address | 1111 Kane Concourse, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.avenuetx.com |
| Phone | 781 652 4500 |
| Currency | USD - US Dollar |
Avenue Therapeutics Key Financial Ratios
Avenue Therapeutics' financial ratios allow both analysts and investors to convert raw data from Avenue Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Avenue Therapeutics over time and compare it to other companies across industries.| Return On Equity | -5.35 | ||||
| Return On Asset | -4.72 | ||||
| Target Price | 8.0 | ||||
| Beta | -0.29 |
Avenue Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Avenue Therapeutics's current stock value. Our valuation model uses many indicators to compare Avenue Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avenue Therapeutics competition to find correlations between indicators driving Avenue Therapeutics's intrinsic value. More Info.Avenue Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Avenue Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Avenue Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Avenue Therapeutics Systematic Risk
Avenue Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Avenue Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Avenue Therapeutics correlated with the market. If Beta is less than 0 Avenue Therapeutics generally moves in the opposite direction as compared to the market. If Avenue Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Avenue Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Avenue Therapeutics is generally in the same direction as the market. If Beta > 1 Avenue Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Avenue Therapeutics March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Avenue Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Avenue Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Avenue Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Avenue Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Avenue Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 61.43 | |||
| Value At Risk | (12.00) | |||
| Potential Upside | 7.59 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Avenue Pink Sheet
If you are still planning to invest in Avenue Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avenue Therapeutics' history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |